The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 30th 2025
Research reveals that children face significant long-term health risks, including kidney, gastrointestinal, and cardiovascular issues, after COVID-19 infection.
US Pharmacopeia Provides Resources to Support Supply Chain Resilience Amid Drug Shortages
January 16th 2025Farah Towfic, PharmD, MBA, RPh, discusses how US Pharmacopeia helped to strengthen supply chain resilience in 2024 through data-driven insights, policy advocacy, and pharmacist engagement to address prolonged drug shortages, particularly for generic sterile injectables.
Watch
Q&A: Prepare for the Future of the AI in 2025
January 15th 2025Jim Dente of Advanced Pharmacy Solutions emphasizes the growing role of automation, artificial intelligence, and patient-centric business models in streamlining operations, improving patient care, and addressing industry challenges such as staff burnout and medication errors.
Read More
Data Show Dyslipidemia as Independent Risk Factor for Primary Open-Angle Glaucoma
January 14th 2025Dyslipidemia is a condition in which there are abnormal levels of lipids in the blood stream, including high levels of low-density lipoprotein cholesterol, low levels of high-density lipoprotein cholesterol, and/or high levels of triglycerides.
Read More
Updates in Cancer Prevention and Screening for 2025: A Pharmacist Primer
January 12th 2025Pharmacists play a vital role in cancer prevention and early detection by educating patients on risk factors, counseling on screening guidelines, and promoting adherence to evidence-based recommendations for common cancers, such as breast, cervical, colorectal, lung, prostate, and skin cancer.
Read More
Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy Practice
January 10th 2025The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.
Read More